From: 26/09/2015 to: 26/09/2015 ESO Session: Is Innovation Affordable?, Vienna, Austria                                        From: 28/10/2015 to: 29/10/2015 ESO Masterclass in Clinical Oncology, Tiblisi, Georgia                                         From: 05/11/2015 to: 07/11/2015 ABC3 - Advanced Breast Cancer Third International Consensus Conference, Lisbon, Portugal                                        From: 12/11/2015 to: 12/11/2015 ESO Conference Personalised Approach to Prostate Cancer Management, Barcelona, Spain                                        From: 16/11/2015 to: 20/11/2015 2nd ESOP-ESO Masterclass in Oncology Pharmacy, Strasbourg, France                                        From: 27/11/2015 to: 28/11/2015 Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology, Rome, Italy                                        From: 12/02/2016 to: 13/02/2016 Active Surveillance for Low Risk Prostate Cancer, Milan, Italy                                        From: 12/03/2016 to: 17/03/2016 15th ESO-ESMO Masterclass in Clinical Oncology, Ermatingen, Switzerland                                        From: 12/03/2016 to: 17/03/2016 9th ESO-EONS Masterclass in Oncology Nursing, Ermatingen, Switzerland                                        From: 06/04/2016 to: 09/04/2016 Update Skills in Head and Neck Surgery and Oncology, Leipzig, Germany                                        From: 09/04/2016 to: 14/04/2016 2nd_ESO-ESSO_Masterclass_in_Breast_Cancer_Surgery, Lisbon, Portugal                                        From: 15/04/2016 to: 16/04/2016 ESNM-ESO Learning Course on 18FDG PET-CT in Lymphoma, Vienna, Austria                                        From: 22/04/2016 to: 23/04/2016 8th Clinical Oncology Update - Onkologia 2016, Kraków, Poland                                        From: 27/04/2016 to: 01/05/2016 2nd ESO-ESMO Latin-American Masterclass in Clinical Oncology, Bogotà, Colombia                                        From: 19/05/2016 to: 20/05/2016 ESO,CNIO and NRCO Conference on Familial Cancer, Madrid, Spain                                        From: 20/05/2016 to: 25/05/2016 3rd ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Bratislava, Slovak Republic                                        From: 10/06/2016 to: 14/06/2016 2nd Masterclass on Systematic Reviews in Cancer Care, Guidelines and Research, Belfast, United Kigdom                                        From: 11/06/2016 to: 16/06/2016 6th ESO-SIOP Europe Masterclass in Paediatric Oncology, Berlin, Germany                                        From: 17/06/2016 to: 18/06/2016 ESGO-ENYGO-ESO Masterclass in Gynaecological Oncology, Lund, Sweden                                        From: 14/07/2016 to: 19/07/2016 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 29/08/2016 to: 09/09/2016 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Poznan, Poland                                        From: 08/09/2016 to: 09/09/2016 Eastern Europe and Balkan Region Refresher Course on Gastro-intestinal Cancer, Budapest, Hungary                                        From: 01/10/2016 to: 02/10/2016 ESO-TUM-IAS Master in Ethical Counselling in Oncology and Gender Issues, Munich, Germany                                        From: 10/11/2016 to: 11/11/2016 3rd Breast Cancer in Young Women Conference, Lugano, Switzerland                                        From: 19/11/2016 to: 23/11/2016 4th ESO-ESTRO Masterclass in Radiation Oncology, Prague, Czech Republic                                        From: 25/11/2016 to: 26/11/2016 Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology, Rome, Italy


The European School of Oncology receives the bulk of its funding through permanent and unrestricted grants from private legacies and donations through its two sustaining foundations: the Swiss-based European School of Oncology Foundation and the Italian Fondazione per la Formazione Oncologica. Additional funding sources include royalties, income from conferences, donations from individual supporters, and grants from commercial companies through its Sharing Progress in Cancer Care programme.

ESO’s financial independence gives it a freedom to set its own agenda that is rare among independent providers of oncology education, enabling it to address topics that are of little interest to commercial companies, including surgery and rare cancers (including childhood tumours), and to fund activities in countries and regions with limited economic resources.

Oncologica  European